Disease Information

Fanconi Anemia Explained

What Is FA?

FA is a genetic disease caused by mutations in any of the known 23 genes (including genes such as BRCA1 and BRCA2) that play a role in the FA DNA repair pathway. FA is considered a cancer-predisposition or cancer-susceptibility disease. Decades of research have revealed that faulty DNA repair causes FA, and individuals with FA are much more likely to develop cancer at a young age.

Learn More

Better Care Now

Clinical Care Guidelines

At Fanconi Cancer Foundation, we are in relentless pursuit of better care, better treatment, and ultimately, a cure for FA and FA-related cancers. Our clinical care guidelines are here as a resource for medical and care team providers who may never have crossed paths with FA before, in hopes they are able to provide better support for patients with FA.

Learn More

Knowledge Is Key

Cancer Awareness and Empowerment

Cancer can be daunting, and it’s natural to want to avoid dwelling on it. At FCF, we understand the weight of this concern for families affected by FA. That’s why we’re committed to partnering with the FA research and medical community to confront this challenge head-on. While experts work tirelessly towards solutions, we encourage you to stay informed without feeling overwhelmed.

Learn More

Stay Informed

Resource Library

Explore our library of educational materials and videos to empower individuals and families impacted by FA. Gain insights, guidance, and understanding to navigate FA’s complexities with more confidence.

Learn More

The Latest

News & Events

2025 Research Updates

Research is the answer to one day making FA a treatable, manageable disease. Here, you'll discover the most recent strides in FA research and activities funded by FCF. Every quarter, we'll bring you updates on newly funded grants, ongoing projects, and significant milestones.

Honoring Dr. John E. Wagner for a Lifetime of Impact

At the 2025 Fanconi Cancer Foundation Scientific Symposium in Minneapolis, the Foundation presented its Lifetime Achievement Award to Dr. John E. Wagner, MD, in recognition of his decades of groundbreaking work and unwavering commitment to improving the lives of people with Fanconi anemia (FA).

Global Community, Shared Discovery: 2025 Symposium and Adult Retreat Bring FA Collaboration to Life

Nearly 300 members of the global Fanconi anemia community gathered in Minneapolis for the 2025 Scientific Symposium and Retreat for Adults with FA, three days that blended science, lived experience, and hope.